S&P 500 — US Large Cap Index
FTSE 100 — UK Blue Chips
Euro Stoxx 50 — Eurozone Leaders
DAX 40 — German Equities
CAC 40 — French Market Index
Nikkei 225 — Japan Benchmark
Hang Seng — Hong Kong Index
Shanghai Composite — China Mainland
ASX 200 — Australian Market
TSX Composite — Canada Index
Nifty 50 — India Large Cap
STI Index — Singapore Market
KOSPI — South Korea Index
Bovespa — Brazil Equities
JSE Top 40 — South Africa Index
IPC Index — Mexico Market
The Hang Seng Index rose 0.8%, or 188 points, to 25,685 on Thursday, as gains in healthcare and technology stocks lifted the market. Healthcare and biotechnology stocks were among the strongest performers. Everest was the standout after reporting a 157.3% year-on-year increase in first-half revenue to RMB1.15 billion and a swing to RMB97.2 million in non-IFRS net profit, driven largely by its NEFECON kidney-disease treatment. Technology stocks also advanced, with Tencent reporting a 176% year-on-year jump in second-quarter capex to RMB52.8 billion on AI investment, while revenue rose 11% and adjusted earnings gained 9%. Sentiment was further supported by China keeping its one-year and five-year LPRs unchanged at 3.00% and 3.50%. Global bond yields also eased after the US Treasury doubled its long-term debt buybacks, supporting risk appetite. Notable movers included Tencent (0.8%), Xiaomi (2.7%), GenScript Biotech (8.3%), SMIC (1.5%) and WuXi Biologics (4.6%).
